Hinge Bio, Inc. Chief Scientific Officer, Daniel Capon, Ph.D., to Present its GEM-DIMER™ Platform Technology at the University of Oxford, Kennedy Institute of Rheumatology’s Annual Translational Research Conference
August 14, 2024 08:00 ET
|
Hinge Bio, Inc.
BURLINGAME, Calif., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Hinge Bio, Inc., a privately held biotechnology company in the San Francisco Bay Area, today announced that Daniel Capon, Ph.D., Founder &...
Hinge Bio Expands Senior Management Team to Drive GEM-DIMER™ Programs to Clinical Development
January 18, 2023 08:00 ET
|
Hinge Bio, Inc.
Barry Selick, Ph.D., successful biopharmaceutical scientist, senior executive and entrepreneur, appointed Chief Executive Officer Carin Rollins, Hinge Bio co-founder, becomes Chief Operating...